title: The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats.
abstract: BACKGROUND
  Because the role of dopamine (DA) D3 receptors has been investigated primarily in relation to cocaine-related behaviors little is known of the role of these receptors in heroin seeking.
  
  
  OBJECTIVE
  To investigate the effect of the selective DA D3 receptor antagonist, SR 21502, on cue-induced reinstatement of heroin seeking and heroin conditioned place preference (CPP).
  
  
  METHODS
  In experiment 1, rats were trained to self-administer intravenous heroin for 15 days followed by extinction. Following extinction animals were treated with one of several SR 21502 doses (0, 7.5, 10 or 15mg/kg) and a cue-induced reinstatement test was conducted. In experiment 2, animals were conditioned to experience heroin in one compartment of a CPP apparatus and saline in the other. On the test day animals were treated with 0, 3.75, 7.5, 10 or 15mg/kg of SR 21502 and tested for their CPP.
  
  
  RESULTS
  The results from experiment 1 showed a significant dose-related reduction in cue-induced reinstatement of active lever pressing in the 7.5 and 10mg groups and an absence of the reinstatement effect in the 15mg group. In experiment 2, animals treated with vehicle or 3.75mg of SR 21502 showed significant heroin place preferences but those treated with the higher doses showed no CPP.
  
  
  CONCLUSIONS
  Our findings suggest that DA D3 receptors play a significant role in heroin approach behaviors driven by conditioned stimuli. As such, we propose that SR 21502 holds potential as an effective pharmacotherapeutic agent for relapse prevention and should be studied further.
authors.affiliation: CUNY Graduate Center, New York, NY, United States.
authors.forename: Ewa
authors.initials: E
authors.lastname: Galaj
authors.affiliation: Queens College of the City University of New York, Department of Psychology, Flushing, NY, United States.
authors.forename: Monica
authors.initials: M
authors.lastname: Manuszak
authors.affiliation: Queens College of the City University of New York, Department of Psychology, Flushing, NY, United States.
authors.forename: Sandra
authors.initials: S
authors.lastname: Babic
authors.affiliation: Department of Chemistry, Drug Discovery Division, Southern Research Institute, Birmingham, AL, United States.
authors.forename: Subramaniam
authors.initials: S
authors.lastname: Ananthan
authors.affiliation: CUNY Graduate Center, New York, NY, United States; Queens College of the City University of New York, Department of Psychology, Flushing, NY, United States. Electronic address: Robert.Ranaldi@qc.cuny.edu.
authors.forename: Robert
authors.initials: R
authors.lastname: Ranaldi
mesh_terms: D000818:Animals; D003214:Conditioning, Classical / Q000187:drug effects* / Q000502:physiology; D003463:Cues; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005108:Extinction, Psychological / Q000187:drug effects / Q000502:physiology; D005260:Female; D003932:Heroin / Q000008:administration & dosage*; D006556:Heroin Dependence / Q000503:physiopathology* / Q000534:rehabilitation*; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D020318:Rats, Long-Evans; D050637:Receptors, Dopamine D3 / Q000037:antagonists & inhibitors* / Q000502:physiology*; D012008:Recurrence; D012646:Self Administration; D015819:Substance Abuse, Intravenous / Q000503:physiopathology / Q000534:rehabilitation
chemical_list: D007093:Imidazoles; D011725:Pyridines; D050637:Receptors, Dopamine D3; C000593313:SR 21502; D003932:Heroin
keywords: Addiction; D3 receptor antagonist; Heroin; Reinstatement; Reward